<DOC>
	<DOCNO>NCT00394927</DOCNO>
	<brief_summary>The purpose survey explore structured interview patient examination rate distribution neurological systemic adverse effect relate antiepileptic treatment . Adverse effect consideration modify therapy assess pediatric adult patient control well uncontrolled epilepsy different seizure type</brief_summary>
	<brief_title>Adverse Event Scale Patients With Epilepsy ( aEscape ) - A European Survey Physicians With Epilepsy Patients</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Male female patient age 4 year Confirmed diagnosis epilepsy require AED treatment Patients already receive daily AED treatment monotherapy polytherapy maximum 2 AEDs within term market authorization follow medication : Carbamazepine , Clobazam , Clonazepam , Gabapentin , Lamotrigine , Levetiracetam , Oxcarbazepine , Phenobarbital , Phenytoin , Pregabalin , Tiagabine , Topiramate , Valproate , Zonisamide Treatment must stable least 3 month prior assessment Absence severe and/or uncontrolled symptomatic chronic illness</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Non-Interventional</keyword>
	<keyword>Surveillance</keyword>
	<keyword>Adverse Effects</keyword>
	<keyword>AntiEpileptic Drug treatment</keyword>
</DOC>